Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
m-AMSA: a new anticancer agentM Rozencweig, D D Von Hoff, S S Legha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1983
Phase I study of carboplatin given on a five-day intravenous scheduleM Rozencweig, C Nicaise, M Beer, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells in vitroP Dodion, C Sanders, W Rombaut, et al.
Cancer|December 15, 1988
Six-year results of a multimodality treatment strategy for locally advanced breast cancerM J Piccart, D de Valeriola, R Paridaens, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1982
N-(phosphonacetyl)-L-aspartate (PALA) in advanced soft tissue sarcoma: a phase II trial of the EORTC soft tissue sarcoma groupV Bramwell, A Van Oosterom, H T Mouridsen, et al.
Cancer Treatment Reports|May 1, 1986
Phase I study of triglycidylurazol given on a 5-day i.v. scheduleC Nicaise, M Rozencweig, N Crespeigne, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1982
Phase I clinical study of 9-hydroxy-2N-methyl-ellipticinium acetate (NSC-264137) administered on a 5-day i.v. scheduleP Dodion, M Rozencweig, C Nicaise, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Overview of Taxol safetyN Onetto, R Canetta, B Winograd, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1982
Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II studyJ H Mulder, P Dodion, F Cavalli, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Sensitivity of normal human bone marrow myeloid progenitor cells to anthracycline, cisplatin, anthracene and flavone acetic acid derivatives, and its relevance for the prediction of human plasma concentrations of anticancer drugsP Dodion, D Bron, M A Mattelaer, et al.
Pageof 13